Matches in Nanopublications for { ?s ?p "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP430051.RAFDrsxjAAS-OxWLOtL_1-QOAr1JL7_TZwh7J5OGlZsMk130_assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430051.RAFDrsxjAAS-OxWLOtL_1-QOAr1JL7_TZwh7J5OGlZsMk130_provenance.
- NP503021.RAYPsaHBEywMBHSK79NXKypHR7jrYcuCrjlNsVw9-4ke4130_assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503021.RAYPsaHBEywMBHSK79NXKypHR7jrYcuCrjlNsVw9-4ke4130_provenance.
- NP294395.RAQXTLjSFe8gGWXUh98QXyHFx6YJI8h69RzRSfVlfZm4U130_assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294395.RAQXTLjSFe8gGWXUh98QXyHFx6YJI8h69RzRSfVlfZm4U130_provenance.
- NP843052.RAxYpSvk4an6AUtewfJJeu1x7-g5d9jyAXUHHuJtYalmY130_assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843052.RAxYpSvk4an6AUtewfJJeu1x7-g5d9jyAXUHHuJtYalmY130_provenance.
- NP897709.RATOawNnvk165kCOyvZqcDmWE9qLxF8Aqd0nyPxw_mSuM130_assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897709.RATOawNnvk165kCOyvZqcDmWE9qLxF8Aqd0nyPxw_mSuM130_provenance.
- assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_provenance.
- NP1020768.RAIYA7CtWjVYSw3C-HFKUHLx4oM-HDviK2i3ztqsqnoQM130_assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1020768.RAIYA7CtWjVYSw3C-HFKUHLx4oM-HDviK2i3ztqsqnoQM130_provenance.
- NP1020766.RA3_bFDuqL-EOFFi9ZvZ1oW0BNyinMC8zpxDg5OSxXkj4130_assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1020766.RA3_bFDuqL-EOFFi9ZvZ1oW0BNyinMC8zpxDg5OSxXkj4130_provenance.